Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 6.34 -0.16% -0.01
ACHN closed down 0.16 percent on Tuesday, November 12, 2019, on 41 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical ACHN trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.16%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.16%
Narrow Range Bar Range Contraction -0.16%
Inside Day Range Contraction -0.16%
Wide Bands Range Expansion -0.16%

Older signals for ACHN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company's drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Chemistry Biopharmaceutical Chemical Compounds Organic Compounds Infection Cyclopropanes Antiviral Drug Drug Therapies HCV Carbamates Hepatitis C Virus Ns3 Ns5a Protease Inhibitor Sulfonamides
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.46
52 Week Low 1.29
Average Volume 3,290,019
200-Day Moving Average 3.5466
50-Day Moving Average 4.8084
20-Day Moving Average 6.276
10-Day Moving Average 6.356
Average True Range 0.1723
ADX 49.13
+DI 44.2768
-DI 13.763
Chandelier Exit (Long, 3 ATRs ) 5.9431
Chandelier Exit (Short, 3 ATRs ) 3.9969
Upper Bollinger Band 6.4864
Lower Bollinger Band 6.0656
Percent B (%b) 0.65
BandWidth 6.704908
MACD Line 0.4693
MACD Signal Line 0.5351
MACD Histogram -0.0657
Fundamentals Value
Market Cap 867.06 Million
Num Shares 137 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -12.68
Price-to-Sales 33.83
Price-to-Book 1.40
PEG Ratio -0.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.40
Resistance 3 (R3) 6.40 6.38 6.39
Resistance 2 (R2) 6.38 6.36 6.38 6.39
Resistance 1 (R1) 6.36 6.36 6.35 6.36 6.38
Pivot Point 6.34 6.34 6.34 6.34 6.34
Support 1 (S1) 6.32 6.32 6.31 6.32 6.30
Support 2 (S2) 6.30 6.32 6.30 6.29
Support 3 (S3) 6.28 6.30 6.29
Support 4 (S4) 6.28